The Medical Letter on Drugs and Therapeutics
Issue 1524
Drugs for Sexually Transmitted Infections
The full issue is available to subscribers Subscriber Login   
Drugs for Sexually Transmitted Infections
TABLES IN THIS ISSUEDrugs of Choice for Some STIsHuman Papillomavirus (HPV) Vaccine

The text and tables that follow include recommendations for management of sexually transmitted infections (STIs) other than HIV and viral hepatitis. Some of the indications and dosages recommended here have not been approved by the FDA.

PARTNER TREATMENT — Management of STIs should include evaluation and treatment of sex partners of infected persons. If possible, partners should be examined and tested for STIs, but in most cases treatment should be initiated regardless of symptoms and without waiting for laboratory test results.

An alternative approach, particularly for heterosexual patients infected with gonorrhea or chlamydia, is to treat sex partners without direct examination or testing, either by prescription ... more       Show References Hide References

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this issue:
Title: Issue 1524
Select version:
 Downloadable, electronic issue - $35
 Postal, hardcopy issue - $35